Jane Street’s Iovance Biotherapeutics IOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14.7M Buy
4,173,886
+590,076
+16% +$1.89M 0.02% 2089
2025
Q4
$9.78M Buy
3,583,810
+2,170,148
+154% +$5.02M 0.01% 2346
2025
Q3
$3.07M Sell
1,413,662
-593,909
-30% -$1.4M ﹤0.01% 4178
2025
Q2
$3.45M Buy
2,007,571
+1,886,481
+1,558% +$4.69M 0.01% 3545
2025
Q1
$403K Sell
121,090
-174,138
-59% -$898K ﹤0.01% 7260
2024
Q4
$2.18M Buy
295,228
+178,258
+152% +$1.65M ﹤0.01% 3948
2024
Q3
$1.1M Sell
116,970
-913,342
-89% -$8.65M ﹤0.01% 5692
2024
Q2
$8.26M Buy
1,030,312
+9,245
+0.9% +$99.1K 0.01% 2255
2024
Q1
$15.1M Buy
1,021,067
+498,506
+95% +$5.8M 0.02% 1426
2023
Q4
$4.25M Sell
522,561
-27,354
-5% -$143K 0.01% 3086
2023
Q3
$2.5M Buy
549,915
+147,598
+37% +$964K ﹤0.01% 3674
2023
Q2
$2.83M Buy
402,317
+336,633
+513% +$2.41M ﹤0.01% 3601
2023
Q1
$401K Sell
65,684
-36,235
-36% -$250K ﹤0.01% 6709
2022
Q4
$651K Buy
101,919
+41,101
+68% +$321K ﹤0.01% 5692
2022
Q3
$583K Sell
60,818
-69,299
-53% -$799K ﹤0.01% 6403
2022
Q2
$1.44M Sell
130,117
-181,203
-58% -$2.37M ﹤0.01% 4794
2022
Q1
$5.18M Buy
311,320
+141,703
+84% +$2.19M 0.01% 2975
2021
Q4
$3.24M Buy
169,617
+57,383
+51% +$1.26M 0.01% 3563
2021
Q3
$2.77M Sell
112,234
-19,762
-15% -$466K 0.01% 3821
2021
Q2
$3.43M Buy
131,996
+48,609
+58% +$1.26M 0.01% 3328
2021
Q1
$2.64M Sell
83,387
-19,750
-19% -$819K 0.01% 3501
2020
Q4
$4.79M Sell
103,137
-70,371
-41% -$2.79M 0.01% 2183
2020
Q3
$5.71M Sell
173,508
-216,990
-56% -$6.65M 0.02% 1717
2020
Q2
$10.7M Buy
390,498
+327,885
+524% +$10.8M 0.04% 1136
2020
Q1
$1.87M Buy
62,613
+33,358
+114% +$884K 0.01% 2083
2019
Q4
$810K Sell
29,255
-3,727
-11% -$84.8K ﹤0.01% 3060
2019
Q3
$600K Sell
32,982
-9,742
-23% -$215K ﹤0.01% 3314
2019
Q2
$1.05M Buy
+42,724
New +$644K 0.01% 2635
2017
Q4
Sell
-21,204
Closed -$164K 4900
2017
Q3
$164K Buy
+21,204
New +$134K ﹤0.01% 4179

Other funds holding IOVA